Clinical Trial Update: A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 study assessing camicinal for gastroparesis symptoms in adults with type 1 or type 2 diabetes; the trial completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Camicinal

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2017-11-01